Skip to main content
SpringerLink
Log in

The province of Quebec has announced that it will include sitagliptin [Januvia], under some reimbursement criteria,

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Merck Frosst.Today brings good news to Quebecers with type 2 diabetes - Quebec is the first province to list JANUVIA(TM) on drug insurance plan. Media Release: 30 Sep 2008. Available from: URL: http://www.merckfrosst.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The province of Quebec has announced that it will include sitagliptin [Januvia], under some reimbursement criteria,. Pharmacoecon. Outcomes News 564, 11 (2008). https://doi.org/10.2165/00151234-200805640-00029

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805640-00029

Keywords

Search

Navigation